Caterina Di Pietro - Concepedia

Author

Caterina Di Pietro

Takeda (Italy)ORCID

Also Known As

C DI Pietro, C Di Pietro, C PIETRO, C. Di Pietro, Caterina Di Pietro, Caterina, Di Pietro, F Bravi

Publications

507

Citations

H-Index

Concepts

All Affiliations

Takeda (Italy)Vita-Salute San Raffaele University Yale University Yale Cancer Center

About

Caterina Di Pietro is an author at Takeda (Italy) specializing in medicine, diabetes, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	178
2	Diabetes	2	2	33
3	Allergy	1	1	145
4	Immunology	1	1	145
5	Microbiology	1	1	145

Caterina Di Pietro

Publications

407

Citations

H-Index

Page 1

	Year	Citations
Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment Jayashree Dolpady, Chiara Sorini, Caterina Di Pietro, Journal of Diabetes Research Chronic Inflammatory DiseasesDysbiosisInnate Immune SystemImmunologyImmune Regulation	2015	145
Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis Hasan Halit Öz, Ee-chun Cheng, Caterina Di Pietro, Cell Reports	2022	59
Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophages Caterina Di Pietro, Pingxia Zhang, Timothy K. O’Rourke, Scientific Reports	2017	49
On/Off TLR Signaling Decides Proinflammatory or Tolerogenic Dendritic Cell Maturation upon CD1d-Mediated Interaction with Invariant NKT Cells Simone Caielli, Cristina Conforti‐Andreoni, Caterina Di Pietro, The Journal of Immunology	2010	40
Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes G. Perriello, Simone Pampanelli, Caterina Di Pietro, Diabetic Medicine	2006	38
Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens A. Gaddi, Danilo Benedetto, Fabio Capello, Public Health Diabetes ManagementInsulin ManagementDiabetesPharmacologyOral Antidiabetic Therapy	2013	18
Effects of Pioglitazone in Combination with Metformin or a Sulfonylurea Compared to a Fixed-Dose Combination of Metformin and Glibenclamide in Patients with Type 2 Diabetes Marco Comaschi, A Demicheli, Caterina Di Pietro, Diabetes Technology & Therapeutics	2007	16
The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia Marco Comaschi, A. Corsi, Caterina Di Pietro, Nutrition Metabolism and Cardiovascular Diseases Metabolic SyndromeDiabetes ManagementDiabetesPharmacologyPharmacotherapy	2007	15
Increased β-Cell Mass by Islet Transplantation and <i>PLAG1</i> Overexpression Causes Hyperinsulinemic Normoglycemia and Hepatic Insulin Resistance in Mice Jeroen Declercq, Anujith Kumar, Janna A. van Diepen, Diabetes	2010	14
MicroRNA-133b Regulation of Th-POK Expression and Dendritic Cell Signals Affect NKT17 Cell Differentiation in the Thymus Caterina Di Pietro, Lorena De Giorgi, Ilaria Cosorich, The Journal of Immunology	2016	13

Page 1